Theravance (Nasdaq:THRX) is a biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
Recent Mentions on Fool.com
- 3 Can't-Miss FDA Actions Coming in December
- Glaxo and Theravance Get European Marketing Approval for Relvar Ellipta
- 5 Ways a Government Shutdown Could Negatively Impact Your Portfolio
- Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
- Sanofi's Interest Sparks Biotech Stocks in a Huge Week for Investors